Rajiv De Silva
-
Auxilium Ditches QLT For Better Endo Buyout Offer
Chesterbrook specialty biopharmaceutical developer Auxilium Pharmaceuticals Inc. will no longer chase an inversion-inspired merger with Canada’s QLT Inc. now that Endo International, whose U.S. headquarters is in nearby…
-
Endo Announces Settlement Of Vaginal Mesh Claims
Endo International said Sept. 30 the firm reached master settlement agreements with several law firms representing leading plantiffs to resolve claims over vaginal mesh products…
-
Endo Makes Unsolicited Offer To Acquire Auxilium
Endo International has delivered a proposal to acquire all outstanding shares of Auxilium Pharmaceuticals, a move that would give Auxilium shareholders immediate cash value and…
-
Endo Pharmaceuticals Finalizes DAVA Pharma Acquisition
Endo International plc announced Aug. 6 it completed the acquisition of DAVA Pharmaceuticals, Inc., a privately-held company specializing in generic pharmaceuticals. The purchase price was $575…
-
Endo Raises Financial Guidance For 2014
Endo International plc is reporting second quarter 2014 revenues of $719 million – up 1 percent over the 2013 $712 million figure. “Endo delivered strong performance…
-
Endo Purchases Somar Of Mexico City
Endo International plc, with headquarters in Malvern and Dublin, Ireland, has just acquired Grupo Farmaceutico Somar, a leading, privately owned specialty pharmaceuticals company based in Mexico…
-
Endo Sells A Slice Of Its Future To Former VP
After leaving Endo Pharmaceuticals to lead a new research and development company, the former senior vice president of discovery and early development for the Malvern-based…
-
Endo Swallows Fort Lee Generic Pill Maker
Pharmaceutical developer and manufacturer Endo International, which is headquartered in Malvern, agreed to swallow up generic drug maker DAVA Pharmaceuticals, and a spoonful of “meaningful…
-
Endo Shareholders Approve Purchase Of Paladin Labs Of Montreal
Shareholders of Endo Health Solutions, Inc. of Malvern recently approved the acquisition of Paladin Labs, Inc. of Montreal, Canada. Paladin is an international specialty pharmaceutical…
-
Regulatory Infraction Costs Malvern Pharmaceutical Firm $193 Million
While Malvern based Endo Pharmaceuticals, Inc. has been successful marketing branded products to help people live healthier lives, its marketing practices – which stepped outside…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
